sb 202190 has been researched along with Respiratory Tract Neoplasms in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Respiratory Tract Neoplasms: New abnormal growth of tissue in the RESPIRATORY SYSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beum, PV | 1 |
| Bastola, DR | 1 |
| Cheng, PW | 1 |
1 other study available for sb 202190 and Respiratory Tract Neoplasms
| Article | Year |
|---|---|
Mucin biosynthesis: epidermal growth factor downregulates core 2 enzymes in a human airway adenocarcinoma cell line.
Topics: Adenocarcinoma; Carbohydrate Sequence; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; | 2003 |